Charles River Laboratories Total Current Liabilities 2010-2024 | CRL

Charles River Laboratories total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Charles River Laboratories total current liabilities for the quarter ending September 30, 2024 were $1.012B, a 1.85% increase year-over-year.
  • Charles River Laboratories total current liabilities for 2023 were $1.055B, a 3.34% decline from 2022.
  • Charles River Laboratories total current liabilities for 2022 were $1.092B, a 5.65% increase from 2021.
  • Charles River Laboratories total current liabilities for 2021 were $1.033B, a 23.03% increase from 2020.
Charles River Laboratories Annual Total Current Liabilities
(Millions of US $)
2023 $1,055
2022 $1,092
2021 $1,033
2020 $840
2019 $710
2018 $558
2017 $464
2016 $430
2015 $312
2014 $295
2013 $247
2012 $342
2011 $217
2010 $260
2009 $250
Charles River Laboratories Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $1,012
2024-06-30 $948
2024-03-31 $955
2023-12-31 $1,055
2023-09-30 $994
2023-06-30 $1,008
2023-03-31 $981
2022-12-31 $1,092
2022-09-30 $1,014
2022-06-30 $1,048
2022-03-31 $994
2021-12-31 $1,033
2021-09-30 $984
2021-06-30 $930
2021-03-31 $803
2020-12-31 $840
2020-09-30 $787
2020-06-30 $728
2020-03-31 $691
2019-12-31 $710
2019-09-30 $682
2019-06-30 $636
2019-03-31 $530
2018-12-31 $558
2018-09-30 $540
2018-06-30 $518
2018-03-31 $407
2017-12-31 $464
2017-09-30 $416
2017-06-30 $424
2017-03-31 $383
2016-12-31 $430
2016-09-30 $412
2016-06-30 $413
2016-03-31 $310
2015-12-31 $312
2015-09-30 $314
2015-06-30 $277
2015-03-31 $270
2014-12-31 $295
2014-09-30 $283
2014-06-30 $272
2014-03-31 $239
2013-12-31 $247
2013-09-30 $235
2013-06-30 $226
2013-03-31 $331
2012-12-31 $342
2012-09-30 $325
2012-06-30 $328
2012-03-31 $224
2011-12-31 $217
2011-09-30 $224
2011-06-30 $277
2011-03-31 $308
2010-12-31 $260
2010-09-30 $237
2010-06-30 $246
2010-03-31 $247
2009-12-31 $250
2009-09-30 $254
2009-06-30 $270
2009-03-31 $280
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00